XML 16 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Cash Flows From Operating Activities              
Net loss $ (3,619) $ (1,709) $ (6,505) $ (4,549) $ (5,328) $ (11,054)  
Adjustments to reconcile net loss to net cash used in operating activities              
Depreciation 0   708   1,189  
Stock-based compensation expense         1,679 3,908  
Warrant modification expense     139 139  
Loss on sale of business unit         127  
Extinguishment of note payable (1,131)     (2,406)  
Amortization of note discount 2,731   117   3,822 117  
(Gain) loss on sale of property and equipment     (82) 47  
Change in operating assets and liabilities              
Prepaid expenses and other current assets         (220) 438  
Intangible digital assets         (54) (203)  
Right of use asset         36  
Lease liability         (37)  
Other assets         4 (368)  
Accounts payable         (46) (223)  
Accrued expenses         83 566  
Net cash used in operating activities         (2,549) (5,317)  
Cash Flows From Investing Activities              
Proceeds from sale of cybersecurity assets         60  
Purchase of property and equipment         (72) (6,994)  
Proceeds from sale of property and equipment         427  
Net cash used in investing activities         (72) (6,507)  
Cash Flows From Financing Activities              
Proceeds from sale of common stock         525 80  
Payment of deferred offering costs         (70) (83)  
Proceeds from the issuance of notes payable, net of original issue discount         3,700  
Proceeds from sale of stock under equity purchase agreement, net of issuance costs         3,329  
Sale of preferred stock, net of issuance costs         1,890  
Repayment of notes payable         (210)  
Proceeds from exercise of warrants         120 906  
Net cash provided by financing activities         5,584 4,603  
Net change in cash and cash equivalents         2,963 (7,221)  
Cash and cash equivalents, beginning of period   $ 96   $ 9,519 96 9,519 $ 9,519
Cash and cash equivalents, end of period $ 3,059   $ 2,298   3,059 2,298 $ 96
Supplemental disclosure of cash flow information              
Cash paid for interest          
Cash paid for income tax          
Non-cash investing and financing activities              
Deemed dividend on warrant modification and beneficial conversion feature of preferred stock         959  
Deemed dividend on triger of down round provision         2,514  
Stock issued for services not yet rendered         15  
Cumulative effect adjustment related to ASU adoption         3  
Conversion of notes payable into common stock         1,697  
Repayment of note payable and interest through the issuance of shares under the equity purchase agreement         354  
Non-cash deferred offering costs         62  
Conversion of Series C convertible preferred stock into common stock         $ 14